Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 20 February 2009, doi:10.1136/bmj.b731
Cite this as: BMJ 2009;338:b731
The governments decisions compromise its commitment to evidence based policy
| The first 150 words of the full text of this article appear below. |
In the United Kingdom medicinal drugs and treatments are regulated through the 1968 Medicines Act and illegal drugs through the 1971 Misuse of Drugs Act. The Misuse of Drugs Act defines controlled substances on the basis of their potential harm, taking no account of benefits that users might claim. The distinction between medicines and illicit drugs is, of course, not sharp, and many valuable medicines (including Ritalin, GBH (
hydroxybutyrate), tranquillisers, and analgesics) turn into dangerous killers when they escape on to the streets.
The Misuse of Drugs Act established the Advisory Council on the Misuse of Drugs (ACMD) "to keep under review the situation in the United Kingdom with respect to drugs which are being or appear to them likely to be misused and of which the misuse is having or appears to them capable of having harmful effects sufficient to constitute a social problem." The council currently has
Colin Blakemore, professor of neuroscience
1 Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU
colin.blakemore@clneuro.ox.ac.uk
Read all Rapid Responses